Cargando…
T-Cell Receptor Repertoire Sequencing in the Era of Cancer Immunotherapy
T cells are integral components of the adaptive immune system, and their responses are mediated by unique T-cell receptors (TCR) that recognize specific antigens from a variety of biological contexts. As a result, analyzing the T-cell repertoire offers a better understanding of immune responses and...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011887/ https://www.ncbi.nlm.nih.gov/pubmed/36413126 http://dx.doi.org/10.1158/1078-0432.CCR-22-2469 |
_version_ | 1784906499604086784 |
---|---|
author | Frank, Meredith L. Lu, Kaylene Erdogan, Can Han, Yi Hu, Jian Wang, Tao Heymach, John V. Zhang, Jianjun Reuben, Alexandre |
author_facet | Frank, Meredith L. Lu, Kaylene Erdogan, Can Han, Yi Hu, Jian Wang, Tao Heymach, John V. Zhang, Jianjun Reuben, Alexandre |
author_sort | Frank, Meredith L. |
collection | PubMed |
description | T cells are integral components of the adaptive immune system, and their responses are mediated by unique T-cell receptors (TCR) that recognize specific antigens from a variety of biological contexts. As a result, analyzing the T-cell repertoire offers a better understanding of immune responses and of diseases like cancer. Next-generation sequencing technologies have greatly enabled the high-throughput analysis of the TCR repertoire. On the basis of our extensive experience in the field from the past decade, we provide an overview of TCR sequencing, from the initial library preparation steps to sequencing and analysis methods and finally to functional validation techniques. With regards to data analysis, we detail important TCR repertoire metrics and present several computational tools for predicting antigen specificity. Finally, we highlight important applications of TCR sequencing and repertoire analysis to understanding tumor biology and developing cancer immunotherapies. |
format | Online Article Text |
id | pubmed-10011887 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Association for Cancer Research |
record_format | MEDLINE/PubMed |
spelling | pubmed-100118872023-03-15 T-Cell Receptor Repertoire Sequencing in the Era of Cancer Immunotherapy Frank, Meredith L. Lu, Kaylene Erdogan, Can Han, Yi Hu, Jian Wang, Tao Heymach, John V. Zhang, Jianjun Reuben, Alexandre Clin Cancer Res Reviews T cells are integral components of the adaptive immune system, and their responses are mediated by unique T-cell receptors (TCR) that recognize specific antigens from a variety of biological contexts. As a result, analyzing the T-cell repertoire offers a better understanding of immune responses and of diseases like cancer. Next-generation sequencing technologies have greatly enabled the high-throughput analysis of the TCR repertoire. On the basis of our extensive experience in the field from the past decade, we provide an overview of TCR sequencing, from the initial library preparation steps to sequencing and analysis methods and finally to functional validation techniques. With regards to data analysis, we detail important TCR repertoire metrics and present several computational tools for predicting antigen specificity. Finally, we highlight important applications of TCR sequencing and repertoire analysis to understanding tumor biology and developing cancer immunotherapies. American Association for Cancer Research 2023-03-14 2022-11-22 /pmc/articles/PMC10011887/ /pubmed/36413126 http://dx.doi.org/10.1158/1078-0432.CCR-22-2469 Text en ©2022 The Authors; Published by the American Association for Cancer Research https://creativecommons.org/licenses/by-nc-nd/4.0/This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license. |
spellingShingle | Reviews Frank, Meredith L. Lu, Kaylene Erdogan, Can Han, Yi Hu, Jian Wang, Tao Heymach, John V. Zhang, Jianjun Reuben, Alexandre T-Cell Receptor Repertoire Sequencing in the Era of Cancer Immunotherapy |
title | T-Cell Receptor Repertoire Sequencing in the Era of Cancer Immunotherapy |
title_full | T-Cell Receptor Repertoire Sequencing in the Era of Cancer Immunotherapy |
title_fullStr | T-Cell Receptor Repertoire Sequencing in the Era of Cancer Immunotherapy |
title_full_unstemmed | T-Cell Receptor Repertoire Sequencing in the Era of Cancer Immunotherapy |
title_short | T-Cell Receptor Repertoire Sequencing in the Era of Cancer Immunotherapy |
title_sort | t-cell receptor repertoire sequencing in the era of cancer immunotherapy |
topic | Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011887/ https://www.ncbi.nlm.nih.gov/pubmed/36413126 http://dx.doi.org/10.1158/1078-0432.CCR-22-2469 |
work_keys_str_mv | AT frankmeredithl tcellreceptorrepertoiresequencingintheeraofcancerimmunotherapy AT lukaylene tcellreceptorrepertoiresequencingintheeraofcancerimmunotherapy AT erdogancan tcellreceptorrepertoiresequencingintheeraofcancerimmunotherapy AT hanyi tcellreceptorrepertoiresequencingintheeraofcancerimmunotherapy AT hujian tcellreceptorrepertoiresequencingintheeraofcancerimmunotherapy AT wangtao tcellreceptorrepertoiresequencingintheeraofcancerimmunotherapy AT heymachjohnv tcellreceptorrepertoiresequencingintheeraofcancerimmunotherapy AT zhangjianjun tcellreceptorrepertoiresequencingintheeraofcancerimmunotherapy AT reubenalexandre tcellreceptorrepertoiresequencingintheeraofcancerimmunotherapy |